In the first quarter, BASF BAS continued to rely on its diversified product mix in what has been a challenging market environment for chemical producers. BASF’s agriculture and oil and gas businesses propped up sales in the first quarter, as revenues increased 4.8% year over year. On a geographic basis, management noted that growth in…
In this article, we take a look at two stocks which have been in news recently, AcelRx Pharmaceuticals (ACRX) & Nymox Pharmaceuticals (NYMX). Keep an eye out for both these active stocks which have been performing well on the wall street. AcelRx Pharmaceuticals (ACRX) should win FDA approval for the Zalviso pain-killing device on July…
In this article, we take a look at two stocks which have been in news recently, Prana Biotech Ltd (NASDAQ PRAN) & Applied Genetic Corp (NASDAQ AGTC). Keep an eye out for both these active stocks which have been performing well on the wall street. With new recruits coming in for either of them, the…
Credit Suisse CS earned CHF 1,026 million (CHF 0.76 per diluted share) in the first quarter compared with CHF 41 million in the year-ago quarter and CHF 221 million in the trailing quarter on better trading results and lower expenses. This quarter’s reported profit, which included CHF 80 million of noncash own-debt losses, amounted to…
Off late, Biotech stocks have seen some volatility. Here we look at two promising stocks: Veracyte Inc. (NASDAQ VCYT) & RXi Corp (NASDAQ RXII). Both had some major announcements to be made in the past month and the stocks have since shown some very positive upside. Veracyte Inc (NASDAQ VCYT) a molecular diagnostics company pioneering…
Here in this article, we take a look at two very promising Biotech stock: Celldex Therapeutics Inc (NASDAQ CLDX) & Dyax Corp (NASDAQ DYAX). Dyax Corp (NASDAQ DYAX) has had the stock price surge after the company made some major announcements in the past couple of months. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is hoping for similar…
